Novo Nordisk CEO on latest trials, U.S. obesity and demand outlook

Novo Nordisk president and CEO Lars Fruergaard Jørgensen joins 'Money Movers' to discuss the company's latest trial results, how they fit into the weight-loss medicine landscape, and the supply-demand picture for Novo Nordisk's products.